Posted on 1/17/17
Toast Restaurant POS Announces Massive 2016 Growth with Over $2 Billion in Transactions
BOSTON, Jan. 17, 2017 (GLOBE NEWSWIRE) -- Toast Restaurant POS, the all-in-one restaurant technology platform, today announced massive growth in 2016, closing the year with over . . .
Posted on 1/17/17
Margulies Perruzzi Architects Completes Expansion of Spaulding Rehabilitation Hospital Cape Cod
Margulies Perruzzi Architects (MPA), one of Boston’s most innovative architectural and interior design firms, announced
Posted on 1/17/17
Fidelity Biotech Fund: Better than the Index?
IMAGE SOURCE: GETTY IMAGES.Of all the Fidelity mutual funds, its healthcare-focused funds have some of the best records. The Fidelity Select Biotechnology Portfolio (NASDAQMUTFUND:FBIOX) is no . . .
Posted on 1/17/17
Is Donald Trump Big Pharma's Worst Nightmare?
President-elect Donald Trump pulled no punches when it came to big pharma in a press conference on Wednesday: He said that pharmaceutical companies "are getting away . . .
Posted on 1/17/17
Trumpcare, Not Obamacare, Could Be a Job Killer
IMAGE SOURCE: DISNEY-ABC TELEVISION GROUP, FLICKR.In less than one week's time Donald Trump is set to become the 45th president of the United States, which seemed . . .
Posted on 1/17/17
iCannaKorp Raises $4.1M Series A
CannaKorp™ Inc., the makers of the world's first single-use, pod-based cannabis vaporizing system, announced today that
Posted on 1/13/17
Aetna Launches $200m Vitality Re VIII Health Insurance Linked ILS
Health insurance giant Aetna (NYSE:AET) has returned to the insurance-linked securities (ILS) market for its eighth Vitality Re transaction, launching a Vitality Re VIII Ltd. (Series . . .
Posted on 1/12/17
DarioHealth Corp. Announces $5.1 Million Private Placement
DarioHealth Corp. (NASDAQ: DRIO), a leader in digital health and mobile health solutions, announced today the execution of definitive agreements for an aggregate raise of $5.1 . . .
Posted on 1/12/17
BERG Enters into Multi-Year Agreement with BD
BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, announced a multi-year agreement between BERG Analytics, a division of BERG, and BD's . . .
Posted on 1/12/17
3 Charts Every Bristol-Myers Squibb Shareholder Needs to See
Bristol-Myers Squibb (NYSE:BMY) shareholders were understandably disappointed in August when results from a late-stage study of Opdivo as a first-line lung cancer treatment were announced. Opdivo's . . .
Posted on 1/12/17
Merck Muscles Into Bristol's Combo Space
Acceptance of an additional regulatory filing is normally a footnote. The exception to this rule is Merck & Co. (NYSE:MRK), whose market cap this morning gained . . .
Posted on 1/12/17
Why Novartis Dropped 15.1% in 2016
IMAGE SOURCE: GETTY IMAGES.What happenedInvestors in the Swiss pharma giant Novartis (NYSE:NVS) had a rough 2016. The company's stock swooned by more than 15% during the . . .
Posted on 1/12/17
Maverick Therapeutics and Takeda Announce Five-year Collaboration
BRISBANE, Calif. & CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Maverick Therapeutics Inc., an MPM Capital portfolio company, and Takeda Pharmaceutical Company Limited (TSE:4502) announced today that they . . .
Posted on 1/12/17
ProEx Physical Therapy’s Molly Forman Now Practicing in Beverly Location
ProEx, a physical therapist owned private practice specializing in orthopedics, spine and sports medicine is pleased to announce that Physical Therapist Molly Forman is now practicing . . .
Posted on 1/11/17
Peak Physical Therapy & Sports Performance Offers Dry Needling Therapy
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide holistic treatment in orthopedic, spine and sports medicine specialties, announces . . .
Posted on 1/11/17
Merrimack Falls For $1bn Oncology Offer From Ipsen
If not a match made in heaven, Ipsen’s (OTC:IPSEF) (OTCPK:IPSEY) $575m up-front deal to acquire Merrimack Pharmaceuticals’ (NASDAQ:MACK) oncology business is a marriage of convenience on . . .
Posted on 1/11/17
ZIOPHARM and Intrexon Announce Cooperative Research and Development Agreement with the National Cancer Institute
ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on new immunotherapies, and Intrexon Corporation (NYSE:XON), a leader in the engineering and industrialization of biology to improve . . .
Posted on 1/11/17
Sarepta Therapeutics Enters into Research Agreement and Option Agreement with Nationwide Children’s Hospital
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial stage developer of innovative RNA-targeted therapeutics, today announced it has entered a research and option agreement with Nationwide . . .
Posted on 1/10/17
Sanofi and ImmuNext Enter into Agreement to Develop Treatments for Autoimmune Diseases
Sanofi and ImmuNext, Inc., announced today an agreement focused on the development of a novel antibody with the potential to treat a range of autoimmune diseases . . .
Posted on 1/10/17
EMD Serono and MD Anderson Cancer Center Enter Three-Year Strategic Collaboration
EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, and The University of Texas MD Anderson Cancer Center today announced . . .
Posted on 1/10/17
Anokion Announces Strategic Collaboration With Celgene
LAUSANNE, Switzerland & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anokion, a privately held biopharmaceutical company developing novel tolerance-inducing therapeutics for autoimmune diseases, today announced the formation of an exclusive global . . .
Posted on 1/10/17
Zebra Biologics to Collaborate with AbbVie
CONCORD, Mass.--(BUSINESS WIRE)--Zebra Biologics Inc., an emerging pre-clinical stage biotechnology company, today announced that the company has entered into a collaboration with AbbVie to discover agonist . . .
Posted on 1/9/17
Quanterix’ Momentum Fuels Vision for the Future of Precision Health
LEXINGTON, Mass.--(BUSINESS WIRE)--Quanterix Corporation, a company digitizing biomarker analysis to advance the science of precision health, today announced significant milestones that are shaping the future of . . .
Posted on 1/9/17
Moderna Provides Pipeline and Full-Year Corporate Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) Therapeutics™ to create a new generation of transformative medicines for patients, . . .
Posted on 1/9/17
AMAG Pharmaceuticals Provides Financial and Business Update
WALTHAM, Mass., Jan. 09, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today provided a business update, including announcing preliminary unaudited fourth quarter and annual 2016 . . .
Boston
